A Novel Conditionally Active Bispecific HER2 X CD-3 T Cell Engager Targeting Solid Tumors

November 13, 2023

Novel Conditionally Active Bispecific HER2 X CD3 T-Cell Engager Targeting Solid Tumors

April 17, 2023

Novel conditionally active ADCs (CAB ADCs): A novel class of molecules targeting solid tumors

February 2, 2023